reports
- GlobalData Healthcare Department
Camurus AB (CAMX) - Financial Analysis Review
Camurus AB (CAMX) - Financial Analysis Review Summary Camurus AB (Camurus), a subsidiary of Sandberg Development AB focuses on the development and commercialization of specialty medicines for the treatment of chronic diseases such as cancer and pain. The company offers its products through its proprietary FluidCrystal drug delivery technologies such as injection depot, topical bioadhesive delivery, and nanoparticle delivery technologies. GlobalData's Camurus AB (CAMX) - Financial Analysis Rev...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.